The Dana-Farber Cancer Institute, an affiliate of the Harvard Medical School, will retract or correct dozens of papers by four top cancer researchers following the results of a data falsification investigation.

Six papers will be retracted entirely, and 31 will have corrections issued, per the results of an investigation started after allegations of data manipulation against the institute’s president and CEO, Laurie H. Glimcher, and three other researchers.

Recommended Stories

Who is Bill Ackman? The hedge fund billionaire who has MIT and Business Insider in his sights

The Harvard Corporation is just as bad as, if not worse than, Claudine Gay

Black Harvard alumnae demand DEI pledge for hiring and admissions